XML 29 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Fair Value Assumptions and Methodology [Abstract]      
Weighted average grant date fair value of grants (in dollars per share) $ 22.10 $ 13.31 $ 9.98
Risk-free interest rate (in hundredths) 1.40% [1] 0.80% [1] 1.80% [1]
Dividend yield (in hundredths) 3.10% [2] 2.70% [2] 2.60% [2]
Expected volatility (in hundredths) 41.70% [3] 46.80% [3] 38.40% [3]
Expected life 62 months [4] 58 months [4] 63 months [4]
Options, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares) 5,962,200    
Granted (in shares) 2,778,000    
Exercised (in shares) (2,038,400)    
Forfeited/cancelled/expired (in shares) (58,900)    
Outstanding, Ending (in shares) 6,642,900 5,962,200  
Exercisable (in shares) 3,589,700    
Weighted-average Exercise Price [Abstract]      
Outstanding, beginning balance (in dollars per share) $ 22.90    
Granted (in dollars per share) $ 78.57    
Exercised (in dollars per share) $ 19.65    
Forfeited/cancelled/expired (in dollars per share) $ 32.54    
Outstanding, Ending (in dollars per share) $ 47.10 $ 22.90  
Exercisable (in dollars per share) $ 23.23    
Outstanding options, weighted-average remaining contractual term 4 years 5 months 19 days    
Exercisable options, weighted-average remaining contractual term 2 years 9 months 29 days    
Aggregate intrinsic value $ 605,322,000    
Aggregate intrinsic value, exercisable 412,774,000    
Weighted-average Grant Date Fair Value [Abstract]      
Granted (in dollars per share) $ 78.57    
Unrecognized stock-based compensation expense, period for recognition 4 years 5 months 19 days    
Stock Options [Member]
     
Weighted-average Exercise Price [Abstract]      
Outstanding options, weighted-average remaining contractual term 4 years    
Total fair value of options vested and expensed, net of tax 13,200,000    
Cash proceeds from stock options exercised 37,900,000 8,000,000 29,700,000
Tax benefit realized for stock options exercised 41,900,000 6,300,000 17,400,000
Intrinsic value of stock options exercised 241,700,000 10,600,000 61,600,000
Weighted-average Grant Date Fair Value [Abstract]      
Unrecognized stock-based compensation expense 58,400,000    
Unrecognized stock-based compensation expense, period for recognition 4 years    
Omnibus Incentive Plan [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contractual term of stock options granted (in years) 7 years    
Number of shares authorized for issuance (in shares) 7,000,000    
Share-based compensation arrangement by share-based payment award, terms of award Vesting for the options is performance based, with the options vesting in two installments if the Company's earnings per share equal or exceed the two established performance levels, measured in terms of diluted earnings per share. Fifty percent of the options vest upon earnings per share meeting or exceeding the first performance level and fifty percent of the options vest upon earnings per share meeting or exceeding the second performance level.    
Weighted-average Grant Date Fair Value [Abstract]      
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized 3,200,000    
Performance-Based Options [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation arrangement by share-based payment award, terms of award Vesting for the options is performance based, with the options vesting in three installments if the Company's earnings per share equal or exceed the three established performance levels, measured in terms of diluted earnings per share. One third of the options will vest upon earnings per share meeting or exceeding the first performance level, one third of the options will vest upon earnings per share meeting or exceeding the second performance level and one third of the options will vest upon earnings per share meeting or exceeding the third performance level.    
Options, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares) 2,727,000    
Granted (in shares) 2,605,500    
Exercised (in shares) (794,400)    
Forfeited/cancelled/expired (in shares) (55,000)    
Outstanding, Ending (in shares) 4,483,100    
Exercisable (in shares) 1,826,700    
Weighted-average Exercise Price [Abstract]      
Outstanding, beginning balance (in dollars per share) $ 28.06    
Granted (in dollars per share) $ 77.51    
Exercised (in dollars per share) $ 25.10    
Forfeited/cancelled/expired (in dollars per share) $ 33.89    
Outstanding, Ending (in dollars per share) $ 57.25    
Exercisable (in dollars per share) $ 28.72    
Outstanding options, weighted-average remaining contractual term 5 years 3 months 4 days    
Exercisable options, weighted-average remaining contractual term 3 years 5 months 19 days    
Aggregate intrinsic value 362,975,000    
Aggregate intrinsic value, exercisable 200,034,000    
Weighted-average Grant Date Fair Value [Abstract]      
Granted (in dollars per share) $ 77.51    
Unrecognized stock-based compensation expense, period for recognition 5 years 3 months 4 days    
Service-Based Options [Member]
     
Options, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares) 3,235,200    
Granted (in shares) 172,500    
Exercised (in shares) (1,244,000)    
Forfeited/cancelled/expired (in shares) (3,900)    
Outstanding, Ending (in shares) 2,159,800    
Exercisable (in shares) 1,763,000    
Weighted-average Exercise Price [Abstract]      
Outstanding, beginning balance (in dollars per share) $ 18.55    
Granted (in dollars per share) $ 94.53    
Exercised (in dollars per share) $ 16.16    
Forfeited/cancelled/expired (in dollars per share) $ 13.45    
Outstanding, Ending (in dollars per share) $ 26.01    
Exercisable (in dollars per share) $ 17.55    
Outstanding options, weighted-average remaining contractual term 2 years 9 months 25 days    
Exercisable options, weighted-average remaining contractual term 2 years 2 months 1 day    
Aggregate intrinsic value 242,347,000    
Aggregate intrinsic value, exercisable 212,740,000    
Weighted-average Grant Date Fair Value [Abstract]      
Granted (in dollars per share) $ 94.53    
Unrecognized stock-based compensation expense, period for recognition 2 years 9 months 25 days    
Non-Vested Restricted Stock [Member]
     
Weighted-average Exercise Price [Abstract]      
Granted (in dollars per share) $ 41.59    
Number of shares [Roll forward]      
Nonvested, beginning balance (in shares) 729,000    
Granted (in shares) 315,800    
Vested (in shares) (305,400)    
Forfeited (in shares) (9,800)    
Nonvested, Ending Balance (in shares) 729,600    
Weighted-average Grant Date Fair Value [Abstract]      
Nonvested, Beginning Balance (in dollars per share) $ 39.68    
Granted (in dollars per share) $ 41.59    
Vested (in dollars per share) $ 34.88    
Forfeited (in dollars per share) $ 42.10    
Nonvested, Ending Balance (in dollars per share) $ 42.48    
Unrecognized stock-based compensation expense $ 16,400,000    
Unrecognized stock-based compensation expense, period for recognition 2 years 2 months 12 days    
Minimum [Member] | Stock Incentive Plan 1996 [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contractual term of stock options granted (in years) 7 years    
Maximum [Member] | Stock Incentive Plan 1996 [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contractual term of stock options granted (in years) 10 years    
[1] The risk-free interest rate is based upon the rate on a zero coupon U.S. Treasury bill, for periods within the contractual life of the option, in effect at the time of the grant.
[2] The dividend yield is based on the average of historical stock prices and actual dividends paid.
[3] Expected volatility is based on the historical volatility of the Company’s stock price, over a period similar to the expected life of the option.
[4] The expected term of the option is based on the historical employee exercise behavior, the vesting terms of the respective option, and a contractual life of either seven or ten years.